Literature DB >> 21424210

Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis.

Hong-Bo Ren1, Tao Yu, Chao Liu, Yan-Qing Li.   

Abstract

OBJECTIVE: Epidemiological evidences indicate that diabetic individuals may have an increased risk of several cancers; however, the relationships between diabetes and risk of cancers of biliary tract or its subsites remain unclear.
METHODS: To provide a quantitative assessment of this relationship, we identified studies by a literature search of Medline (from 1 January 1966) and EMBASE (from 1 January 1974), through 31 July 2010, and by searching the reference lists of pertinent articles. Summary relative risks with corresponding 95% confidence intervals were calculated with a random-effect model.
RESULTS: Analysis of 21 studies (8 case-control and 13 cohort studies) found that diabetes was associated with an increased risk of biliary tract cancer, compared with no diabetes (summary RRs = 1.43, 95% CI = 1.18-1.72), with significant heterogeneity among studies (p = 0.001). The positive association was also found between diabetes and risk of gallbladder cancer or extrahepatic cholangiocarcinoma, but not cancer of ampulla of Vater. No significant publication bias was found.
CONCLUSION: These findings strongly support the link between diabetes and increased risk of cancer of biliary tract and its subsites: gallbladder cancer or extrahepatic cholangiocarcinoma, but not cancer of ampulla of Vater.

Entities:  

Mesh:

Year:  2011        PMID: 21424210     DOI: 10.1007/s10552-011-9754-3

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  31 in total

1.  Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium.

Authors:  Yu Chen; Fen Wu; Eiko Saito; Yingsong Lin; Minkyo Song; Hung N Luu; Prakash C Gupta; Norie Sawada; Akiko Tamakoshi; Xiao-Ou Shu; Woon-Puay Koh; Yong-Bing Xiang; Yasutake Tomata; Kemmyo Sugiyama; Sue K Park; Keitaro Matsuo; Chisato Nagata; Yumi Sugawara; You-Lin Qiao; San-Lin You; Renwei Wang; Myung-Hee Shin; Wen-Harn Pan; Mangesh S Pednekar; Shoichiro Tsugane; Hui Cai; Jian-Min Yuan; Yu-Tang Gao; Ichiro Tsuji; Seiki Kanemura; Hidemi Ito; Keiko Wada; Yoon-Ok Ahn; Keun-Young Yoo; Habibul Ahsan; Kee Seng Chia; Paolo Boffetta; Wei Zheng; Manami Inoue; Daehee Kang; John D Potter
Journal:  Diabetologia       Date:  2017-03-07       Impact factor: 10.122

2.  Glycemic Status and Prognosis of Patients with Squamous Cell Carcinoma of the Esophagus.

Authors:  Akihiko Okamura; Masayuki Watanabe; Yu Imamura; Masaru Hayami; Kotaro Yamashita; Takanori Kurogochi; Shinji Mine
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

3.  Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma.

Authors:  Qing Pang; Ling-Qiang Zhang; Rui-Tao Wang; Jian-Bin Bi; Jing-Yao Zhang; Kai Qu; Su-Shun Liu; Si-Dong Song; Xin-Sen Xu; Zhi-Xin Wang; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

4.  Sex differences in opisthorchiosis and the development of cholangiocarcinoma in Syrian hamster model.

Authors:  Pakkayanee Sudsarn; Nadchanan Wongchalee; Thidarut Boonmars; Porntip Laummaunwai; Yaovaluk Chamgramol; Chawalit Pairojkul; Amornrat Juasook; Sirintip Boonjaraspinyo
Journal:  Parasitol Res       Date:  2013-12-07       Impact factor: 2.289

Review 5.  Diabetes and cancer I: risk, survival, and implications for screening.

Authors:  Adedayo A Onitilo; Jessica M Engel; Ingrid Glurich; Rachel V Stankowski; Gail M Williams; Suhail A Doi
Journal:  Cancer Causes Control       Date:  2012-05-03       Impact factor: 2.506

6.  Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study.

Authors:  Hsueh-Chou Lai; Shih-Ni Chang; Che-Chen Lin; Ching-Chou Chen; Jen-Wei Chou; Cheng-Yuan Peng; Shih-Wei Lai; Fung-Chang Sung; Yu-Fen Li
Journal:  J Gastroenterol       Date:  2012-10-16       Impact factor: 7.527

7.  Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink.

Authors:  Zhiwei Liu; Rotana Alsaggaf; Katherine A McGlynn; Lesley A Anderson; Huei-Ting Tsai; Bin Zhu; Yue Zhu; Sam M Mbulaiteye; Shahinaz M Gadalla; Jill Koshiol
Journal:  Gut       Date:  2018-11-17       Impact factor: 23.059

8.  Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans.

Authors:  V Fedirko; A Lukanova; C Bamia; A Trichopolou; E Trepo; U Nöthlings; S Schlesinger; K Aleksandrova; P Boffetta; A Tjønneland; N F Johnsen; K Overvad; G Fagherazzi; A Racine; M C Boutron-Ruault; V Grote; R Kaaks; H Boeing; A Naska; G Adarakis; E Valanou; D Palli; S Sieri; R Tumino; P Vineis; S Panico; H B As Bueno-de-Mesquita; P D Siersema; P H Peeters; E Weiderpass; G Skeie; D Engeset; J R Quirós; R Zamora-Ros; M J Sánchez; P Amiano; J M Huerta; A Barricarte; D Johansen; B Lindkvist; M Sund; M Werner; F Crowe; K T Khaw; P Ferrari; I Romieu; S C Chuang; E Riboli; M Jenab
Journal:  Ann Oncol       Date:  2012-11-02       Impact factor: 32.976

Review 9.  Diabetes and the Pancreatobiliary Diseases.

Authors:  Muhammad Shafqet; Kaveh Sharzehi
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

Review 10.  Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies.

Authors:  Caiyun Liao; Dongyu Zhang; Chemtai Mungo; D Andrew Tompkins; Amer M Zeidan
Journal:  Gynecol Oncol       Date:  2014-07-27       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.